These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2557122)
1. Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts. Sirinathsinghji DJ; Dunnett SB Brain Res; 1989 Dec; 504(1):115-20. PubMed ID: 2557122 [TBL] [Abstract][Full Text] [Related]
2. Increased proenkephalin mRNA levels in the rat neostriatum following lesion of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): reversal by embryonic nigral dopamine grafts. Sirinathsinghji DJ; Dunnett SB Brain Res Mol Brain Res; 1991 Feb; 9(3):263-9. PubMed ID: 1851529 [TBL] [Abstract][Full Text] [Related]
3. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts. Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221 [TBL] [Abstract][Full Text] [Related]
4. Loss of striatal mu1 opiate binding by substantia nigra lesions in the rat. Bodnar RJ; Clark JA; Cooper ML; Pasternak GW Life Sci; 1988; 43(21):1697-700. PubMed ID: 2848168 [TBL] [Abstract][Full Text] [Related]
5. Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra. Masuo Y; Wang H; Pélaprat D; Chi ZQ; Rostène W Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2520-4. PubMed ID: 1332831 [TBL] [Abstract][Full Text] [Related]
6. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution. Caboche J; Rogard M; Besson MJ Brain Res Dev Brain Res; 1991 Jan; 58(1):111-22. PubMed ID: 1849802 [TBL] [Abstract][Full Text] [Related]
7. Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra. Santiago M; Westerink BH; Rollema H J Neurochem; 1991 Apr; 56(4):1336-42. PubMed ID: 2002346 [TBL] [Abstract][Full Text] [Related]
8. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666 [TBL] [Abstract][Full Text] [Related]
9. Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. Petit F; Hamon M; Fournie-Zaluski MC; Roques BP; Glowinski J Eur J Pharmacol; 1986 Jul; 126(1-2):1-9. PubMed ID: 3019709 [TBL] [Abstract][Full Text] [Related]
10. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra. Smith JA; Leslie FM; Broide RS; Loughlin SE Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904 [TBL] [Abstract][Full Text] [Related]
11. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors. Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392 [TBL] [Abstract][Full Text] [Related]
12. Comparative development of striatal opiate receptors and dopamine revealed by autoradiography and histofluorescence. Moon Edley S; Herkenham M Brain Res; 1984 Jul; 305(1):27-42. PubMed ID: 6331599 [TBL] [Abstract][Full Text] [Related]
13. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion. Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391 [TBL] [Abstract][Full Text] [Related]
14. Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions. Eghbali M; Santoro C; Paredes W; Gardner EL; Zukin RS Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6582-6. PubMed ID: 2819882 [TBL] [Abstract][Full Text] [Related]
15. Changes in striatal mu and delta opioid receptors after transient forebrain ischemia: a quantitative autoradiographic study. Benfenati F; Pich EM; Zoli M; Grimaldi R; Fuxe K; Agnati LF Brain Res; 1991 Apr; 546(1):171-5. PubMed ID: 1649667 [TBL] [Abstract][Full Text] [Related]
16. Nigrostriatal reconstruction after 6-OHDA lesions in rats: combination of dopamine-rich nigral grafts and nigrostriatal "bridge" grafts. Dunnett SB; Rogers DC; Richards SJ Exp Brain Res; 1989; 75(3):523-35. PubMed ID: 2568267 [TBL] [Abstract][Full Text] [Related]
17. Nigral 6-hydroxydopamine lesions equally decrease mu and delta opiate binding to striatal patches: further evidence for a conformationally malleable type 1 opiate receptor. Bowen WD; Pert CB; Pert A Life Sci; 1982 Oct 18-25; 31(16-17):1679-82. PubMed ID: 6296571 [TBL] [Abstract][Full Text] [Related]
18. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. Latimer LG; Duffy P; Kalivas PW J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208 [TBL] [Abstract][Full Text] [Related]
19. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine DP; Leone P; Pocock D; Wise RA J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399 [TBL] [Abstract][Full Text] [Related]
20. Prenatal stress has long-term effects on brain opiate receptors. Insel TR; Kinsley CH; Mann PE; Bridges RS Brain Res; 1990 Mar; 511(1):93-7. PubMed ID: 2158857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]